Consolidated Condensed Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Oct. 02, 2016	Sep. 27, 2015
Cash flows from operating activities
Net earnings	$ 87,412	$ 87,702
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	27,139	27,851
Write-off of assets relating to restructuring and other exit charges	3,982	328
Non-cash write-off of property, plant and equipment	6,300
Derivatives not designated in hedging relationships:
Net losses	177	294
Cash (settlements) proceeds	(866)	801
Provision for doubtful accounts	1,919	2,369
Deferred income taxes	1,280	(3,318)
Non-cash interest expense	694	2,104
Stock-based compensation	9,857	10,338
Gain on sale of facility	0	(4,348)
Reversal of legal accrual, net of fees	0	(799)
Changes in assets and liabilities, net of effects of acquisitions:
Accounts receivable	21,177	40,899
Inventories	(41,205)	(4,799)
Prepaid and other current assets	(10,994)	3,338
Other assets	1,193	(1,195)
Accounts payable	(18,063)	2,577
Accrued expenses	20,625	8,642
Other liabilities	3,293	1,849
Net cash provided by operating activities	113,873	174,620
Cash flows from investing activities
Capital expenditures	(20,713)	(33,519)
Purchase of businesses	(12,392)	(39,079)
Net cash used in investing activities	(32,911)	(62,639)
Cash flows from financing activities
Net (decrease) increase in short-term debt	(676)	5,787
Proceeds from revolving credit borrowings	135,700	270,000
Repayments of revolving credit borrowings	(135,700)	(250,000)
Proceeds from long-term debt	0	300,000
Repayments of Convertible Notes	0	(172,266)
Repayments of long-term debt	(7,500)	(1,875)
Debt issuance costs	0	(4,971)
Option proceeds	5	63
Payment of taxes related to net share settlement of equity awards	(7,644)	(15,348)
Excess tax benefits from exercise of stock options and vesting of equity awards	0	3,450
Purchase of treasury stock	0	(120,637)
Prepayment of accelerated stock repurchase	0	(60,000)
Dividends paid to stockholders	(15,200)	(15,553)
Other	(52)	(45)
Net cash used in financing activities	(31,067)	(61,395)
Effect of exchange rate changes on cash and cash equivalents	(6,916)	1,058
Net increase in cash and cash equivalents	42,979	51,644
Cash and cash equivalents at beginning of period	397,307	268,921
Cash and cash equivalents at end of period	440,286	320,565
Manufacturing Facility
Derivatives not designated in hedging relationships:
Gain on sale of facility	0	(4,348)
Cash flows from investing activities
Proceeds from disposal of property, plant, and equipment	0	9,179
Property, Plant, and Equipment Excluding Manufacturing Facility [Member]
Derivatives not designated in hedging relationships:
Gain on sale of facility	(47)	(13)
Cash flows from investing activities
Proceeds from disposal of property, plant, and equipment	$ 194	$ 780